Catalyst Wire Dossier Catalyst Wire Dossier

25-valent pneumococcal conjugate vaccine

· Inventprise Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for 25-valent pneumococcal conjugate vaccine, covering 2026-03-17 to 2026-03-17. Get the full timeline:

Most recent: Clinical Trial Update: Dose-Ranging Study to Evaluate a 25-Valent Pneumococcal Conjugate Vaccine [Phase 2]

See pricing